Efficient Gene Disruption in Diverse Strains of Toxoplasma gondii Using CRISPR/CAS9

ABSTRACT Toxoplasma gondii has become a model for studying the phylum Apicomplexa, in part due to the availability of excellent genetic tools. Although reverse genetic tools are available in a few widely utilized laboratory strains, they rely on special genetic backgrounds that are not easily implemented in natural isolates. Recent progress in modifying CRISPR (clustered regularly interspaced short palindromic repeats), a system of DNA recognition used as a defense mechanism in bacteria and archaea, has led to extremely efficient gene disruption in a variety of organisms. Here we utilized a CRISPR/CAS9-based system with single guide RNAs to disrupt genes in T. gondii. CRISPR/CAS9 provided an extremely efficient system for targeted gene disruption and for site-specific insertion of selectable markers through homologous recombination. CRISPR/CAS9 also facilitated site-specific insertion in the absence of homology, thus increasing the utility of this approach over existing technology. We then tested whether CRISPR/CAS9 would enable efficient transformation of a natural isolate. Using CRISPR/CAS9, we were able to rapidly generate both rop18 knockouts and complemented lines in the type I GT1 strain, which has been used for forward genetic crosses but which remains refractory to reverse genetic approaches. Assessment of their phenotypes in vivo revealed that ROP18 contributed a greater proportion to acute pathogenesis in GT1 than in the laboratory type I RH strain. Thus, CRISPR/CAS9 extends reverse genetic techniques to diverse isolates of T. gondii, allowing exploration of a much wider spectrum of biological diversity. IMPORTANCE Genetic approaches have proven very powerful for studying the biology of organisms, including microbes. However, ease of genetic manipulation varies widely among isolates, with common lab isolates often being the most amenable to such approaches. Unfortunately, such common lab isolates have also been passaged frequently in vitro and have thus lost many of the attributes of wild isolates, often affecting important traits, like virulence. On the other hand, wild isolates are often not amenable to standard genetic approaches, thus limiting inquiry about the genetic basis of biological diversity. Here we imported a new genetic system based on CRISPR/CAS9, which allows high efficiency of targeted gene disruption in natural isolates of T. gondii. This advance promises to bring the power of genetics to bear on the broad diversity of T. gondii strains that have been described recently. Genetic approaches have proven very powerful for studying the biology of organisms, including microbes. However, ease of genetic manipulation varies widely among isolates, with common lab isolates often being the most amenable to such approaches. Unfortunately, such common lab isolates have also been passaged frequently in vitro and have thus lost many of the attributes of wild isolates, often affecting important traits, like virulence. On the other hand, wild isolates are often not amenable to standard genetic approaches, thus limiting inquiry about the genetic basis of biological diversity. Here we imported a new genetic system based on CRISPR/CAS9, which allows high efficiency of targeted gene disruption in natural isolates of T. gondii. This advance promises to bring the power of genetics to bear on the broad diversity of T. gondii strains that have been described recently.

[1]  J. Dubey.  Toxoplasmosis of Animals and Humans , 2021 .

[2]  Jennifer Doudna,et al.  RNA-programmed genome editing in human cells , 2013, eLife.

[3]  D. Roos,et al.  Insertional mutagenesis and marker rescue in a protozoan parasite: cloning of the uracil phosphoribosyltransferase locus from Toxoplasma gondii. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. de Bono,et al.  Efficient genome editing in Caenorhabditis elegans by CRISPR-targeted homologous recombination , 2013, Nucleic acids research.

[5]  R. Barrangou,et al.  CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes , 2007, Science.

[6]  Jianzhong Xi,et al.  Optimized gene editing technology for Drosophila melanogaster using germ line-specific Cas9 , 2013, Proceedings of the National Academy of Sciences.

[7]  L. Sibley,et al.  Toxoplasma GRA7 effector increases turnover of immunity-related GTPases and contributes to acute virulence in the mouse , 2014, Proceedings of the National Academy of Sciences.

[8]  D. Roos,et al.  Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[9]  E. Lander,et al.  Genetic Screens in Human Cells Using the CRISPR-Cas9 System , 2013, Science.

[10]  Michael S. Behnke,et al.  Phosphorylation of immunity-related GTPases by a Toxoplasma gondii-secreted kinase promotes macrophage survival and virulence. , 2010, Cell host & microbe.

[11]  Michael S. Behnke,et al.  Phenotypic and Gene Expression Changes among Clonal Type I Strains of Toxoplasma gondii , 2009, Eukaryotic Cell.

[12]  G. Church,et al.  Cas9 as a versatile tool for engineering biology , 2013, Nature Methods.

[13]  Michael S. Behnke,et al.  The Polymorphic Pseudokinase ROP5 Controls Virulence in Toxoplasma gondii by Regulating the Active Kinase ROP18 , 2012, PLoS pathogens.

[14]  P. Zhou,et al.  Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineages , 2012, Proceedings of the National Academy of Sciences.

[15]  L. Weiss,et al.  Type II Toxoplasma gondii KU80 Knockout Strains Enable Functional Analysis of Genes Required for Cyst Development and Latent Infection , 2011, Eukaryotic Cell.

[16]  L. Sibley,et al.  Modulation of innate immunity by Toxoplasma gondii virulence effectors , 2012, Nature Reviews Microbiology.

[17]  Hans Clevers,et al.  Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. , 2013, Cell stem cell.

[18]  J. Gigley,et al.  Efficient Gene Replacements in Toxoplasma gondii Strains Deficient for Nonhomologous End Joining , 2009, Eukaryotic Cell.

[19]  J. Ajioka,et al.  Population structure of Toxoplasma gondii: clonal expansion driven by infrequent recombination and selective sweeps. , 2008, Annual review of microbiology.

[20]  Neville E. Sanjana,et al.  Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.

[21]  J. Ajioka,et al.  Recent transcontinental sweep of Toxoplasma gondii driven by a single monomorphic chromosome , 2007, Proceedings of the National Academy of Sciences.

[22]  M. Huynh,et al.  Tagging of Endogenous Genes in a Toxoplasma gondii Strain Lacking Ku80 , 2009, Eukaryotic Cell.

[23]  George M. Church,et al.  Heritable genome editing in C. elegans via a CRISPR-Cas9 system , 2013, Nature Methods.

[24]  James E. DiCarlo,et al.  RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.

[25]  S. Urban,et al.  Intramembrane proteolysis of Toxoplasma apical membrane antigen 1 facilitates host-cell invasion but is dispensable for replication , 2012, Proceedings of the National Academy of Sciences.

[26]  Wei Tang,et al.  Correction of a genetic disease in mouse via use of CRISPR-Cas9. , 2013, Cell stem cell.

[27]  D. Roos,et al.  Tagging genes and trapping promoters in Toxoplasma gondii by insertional mutagenesis. , 1997, Methods.

[28]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[29]  K. Gull,et al.  A novel epitope tag system to study protein targeting and organelle biogenesis in Trypanosoma brucei. , 1996, Molecular and biochemical parasitology.

[30]  D. Roos,et al.  Insertional Tagging, Cloning, and Expression of the Toxoplasma gondii Hypoxanthine-Xanthine-Guanine Phosphoribosyltransferase Gene , 1996, The Journal of Biological Chemistry.

[31]  L. Sibley,et al.  Aldolase is essential for energy production and bridging adhesin-actin cytoskeletal interactions during parasite invasion of host cells. , 2009, Cell host & microbe.

[32]  Yan Cui,et al.  CTCFBSDB 2.0: a database for CTCF-binding sites and genome organization , 2012, Nucleic Acids Res..

[33]  Bing Yang,et al.  Demonstration of CRISPR/Cas9/sgRNA-mediated targeted gene modification in Arabidopsis, tobacco, sorghum and rice , 2013, Nucleic acids research.

[34]  Peter Krawitz,et al.  Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish , 2013, Development.

[35]  Michael S. Behnke,et al.  A Secreted Serine-Threonine Kinase Determines Virulence in the Eukaryotic Pathogen Toxoplasma gondii , 2006, Science.

[36]  S. Jackson,et al.  DNA end-joining: from yeast to man. , 1998, Trends in biochemical sciences.

[37]  J. Ajioka,et al.  Selection at a Single Locus Leads to Widespread Expansion of Toxoplasma gondii Lineages That Are Virulent in Mice , 2009, PLoS genetics.

[38]  K. Hu,et al.  The Motility of a Human Parasite, Toxoplasma gondii, Is Regulated by a Novel Lysine Methyltransferase , 2011, PLoS pathogens.

[39]  Mikako Hayashi,et al.  Role of Mouse and Human Autophagy Proteins in IFN-γ–Induced Cell-Autonomous Responses against Toxoplasma gondii , 2014, The Journal of Immunology.

[40]  Rudolf Jaenisch,et al.  One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.

[41]  G. Marth,et al.  Genetic basis for phenotypic differences between different Toxoplasma gondii type I strains , 2013, BMC Genomics.